Rchr
J-GLOBAL ID：201401015359765245   Update date: Feb. 04, 2024

Yamanaka Ryuya

ヤマナカ リュウヤ | Yamanaka Ryuya
Affiliation and department：
Kyoto Prefectural University of Medicine

About Kyoto Prefectural University of Medicine


Job title： Project Professor
Homepage URL  (1)： https://square.umin.ac.jp/kpum-yamanaka1/index.html
Research field  (3)： Nutrition and health science ,  Tumor diagnostics and therapeutics ,  Neurosurgery
Research keywords  (16)： Autonomic Nervous System ,  Clinical Medical Science ,  Clinical Oncology ,  Immno Oncology ,  Neuro-Oncology ,  Cancer Research ,  Glycoprotein ,  CNS cancer ,  Central Nervous System Disease ,  Chemotherapy ,  Immunotherapy ,  Genome Biology ,  Biomarker ,  Cancer Therapy ,  miRNA ,  Molecular Targeted Therapy
Research theme for competitive and other funds  (31)：
  • 2021 - 2026 Development research of personalized molecular targeted therapy for patients with primary central nervous system lymphomas based on genome and metabolome analysis
  • 2021 - 2025 Development of care programs for to prevent PICS of ICU delirium patients
  • 2022 - 2023 Development of molcular targeted therapy for primary central nervous system lymphomas.
  • 2021 - 2022 Development of molcular targeted therapy for primary central nervous system lymphomas.
  • 2019 - 2022 Development of care program based on autonomic function analysis in patients with cancer.
Show all
Papers (119)：
  • Yasuo Takashima, Momoko Hamano, Kengo Yoshii, Azusa Hayano, Junya Fukai, Yasuo Iwadate, Koji Kajiwara, Hiroaki Hondoh, Ryuya Yamanaka. Reciprocal expression of the immune response genes CXCR3 and IFI44L as module hubs are associated with patient survivals in primary central nervous system lymphoma. International journal of clinical oncology. 2023. 28. 3. 468-481
  • Yasuo Takashima, Atsushi Kawaguchi, Junya Fukai, Yasuo Iwadate, Koji Kajiwara, Hiroaki Hondoh, Ryuya Yamanaka. Survival prediction based on the gene expression associated with cancer morphology and microenvironment in primary central nervous system lymphoma. PloS one. 2021. 16. 6. e0251272
  • Yasuo Takashima, Momoko Hamano, Junya Fukai, Yasuo Iwadate, Koji Kajiwara, Tsutomu Kobayashi, Hiroaki Hondoh, Ryuya Yamanaka. GSEA-assisted gene signatures valid for combinations of prognostic markers in PCNSL. Scientific reports. 2020. 10. 1. 8435-8435
  • Yasuo Takashima, Azusa Hayano, Ryuya Yamanaka. Metabolome analysis reveals excessive glycolysis via PI3K/AKT/mTOR and RAS/MAPK signaling in methotrexate-resistant primary CNS lymphoma-derived cells. Clinical cancer research : an official journal of the American Association for Cancer Research. 2020
  • Yasuo Takashima, Atsushi Kawaguchi, Yasuo Iwadate, Hiroaki Hondoh, Junya Fukai, Koji Kajiwara, Azusa Hayano, Ryuya Yamanaka. miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma. PloS one. 2020. 15. 2. e0229577
ｍore...
MISC (153)：
  • Yasuo Takashima, Ryuya Yamanaka. Application to next generation regenerative medicine for cancer therapy of prognosis prediction factors in primary central nervous system lymphoma. 2020. 3. 13. 1231-1232
  • Yasuo Takashima, Ryuya Yamanaka. Idetification of candidate factors for cancer direct reprogramming in primary central nervous system lymphoma. Medical Science Digest. 2020. 46. 8. 52-53
  • 山中龍也, 高島康郎. 【論文掲載】再発脳腫瘍モデルにおけるがんの代謝経路とATPエネルギー産生経路の解明~代謝物プロファイリングによる次世代医療の基盤研究~. 京都府立医科大学 報道発表. 2020
  • 山中龍也. 【部 門 紹 介】大学院保健看護学研究科 臨床健康科学・臨床腫瘍学. 京都府立医科大学雑誌. 2019. 128. 10. 763-764
  • 高島康郎, 川口淳, 佐藤隆一, 吉田健一, 早野あづさ, 本間順平, 深井順也, 岩立康男, 梶原浩司, 石澤伸, et al. 中枢神経系原発悪性リンパ腫におけるTh1/Th2バランスとPD-1およびPD-L2遺伝子発現による予後予測. 日本分子生物学会年会プログラム・要旨集(Web). 2019. 42nd
ｍore...
Patents (13)：
ｍore...
Books (14)：
  • Primary Central Nervous System Lymphoma Pcnsl: Incidence, Management and Outcomes
    Nova Science Pub Inc 2016 ISBN:1634853229
  • Molecular Considerations and Evolving Surgical Management Issues in the Treatment of Patients with a Brain Tumor.
    INTECH 2015 ISBN:9789535120315
  • Therapeutic Ribonucleic Acids in Brain Tumors
    Springer 2014 ISBN:364242628X
  • Glioma: Immunotherapeutic Approaches (Advances in Experimental Medicine and Biology)
    Springer 2014 ISBN:1461431468
  • Brain Tumors.
    INTECH 2013 ISBN:9789535110583
ｍore...
Lectures and oral presentations  (302)：
  • がんの予防と免疫
    (新春ふるさと講演会 2023)
  • 中枢神経系原発悪性リンパ腫におけるがんの形態及び微小環境に関連する遺伝子の発現パターンによる予後予測
    (第44回日本分子生物学会年会, 横浜市 2021)
  • 中枢神経系原発悪性リンパ腫におけるがん免疫マイクロRNAによる予後予測.
    (第80回日本癌学会学術総会, 横浜市 2021)
  • がんの予防と免疫~免疫力を高める NK(ナチュラルキラー)細胞の活性化
    (【医誠会オンライン公開医学講座】 2021)
  • 心臓血管手術後ICUに入室した患者の入院前と退院時のQOLの変化 ~SF-36を用いて.
    (第48回日本集中治療医学会学術集会, 神戸市 2021)
ｍore...
Works (6)：
  • Target amplicon sequencing analysis in patients with primary central nervous system lymphomas (Ion Ampliseq Comprehensive Cancer Panel) JGAS000258
    Ryuya Yamanaka, Yasuo Takashima, Yasushi Sasaki 2020 - 現在
  • miRNA expression data from primary central nervous system lymphomas (PCNSL) [miRNA-4] GSE151853
    2020 - 現在
  • miRNA expression data from primary central nervous system lymphomas (PCNSL) GSE122011
    Yamanaka R, Takashima Y 2019 - 現在
  • Expression data from glioma patients GSE43378
    Yamanaka R, Kawaguchi A 2016 - 現在
  • Expression data from primary central nervous system lymphoma (PCNSL) patients GSE34771
    Yamanaka R, Kawaguchi A 2012 - 現在
ｍore...
Education (1)：
  • 1976 - 1982 Niigata University Medical School
Professional career (1)：
  • Dr Med Sci (Niigata University)
Work history (11)：
  • 2020/04 - 現在 Kyoto Prefectural University of Medicine Department of Medicine Project Professor
  • 2013/04 - 2020/03 Kyoto Prefectural University of Medicine Laboratory of Molecular Targeted Therapy for Therapy, Graduate school of Medical Sience Professor
  • 2010/04 - 2020/03 Kyoto Prefectural University of Medicine Graduate School for Health Care Science Professor
  • 2006/07 - 2010/03 Kurume University Reserch Center of Innovative Cancer Therapy Professor
  • 2003/04 - 2006/06 Niigata University Deaprtment of Neurosurgery, Brain Research Institute Associate Professor
Show all
Association Membership(s) (8)：
Japanese Society of Clinical Oncology ,  THE JAPANESE CANCER ASSOCIATION ,  THE JAPAN STROKE SOCIETY ,  The Japan Neurosurgical Society ,  日本東洋医学会 ,  THE JAPANESE ASSOCIATION FOR MOLECULAR TARGET THERAPY OF CANCER ,  American Society of Clinical Oncology ,  American Association for Cancer Research
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM